Skip to main content
. Author manuscript; available in PMC: 2015 Sep 15.
Published in final edited form as: J Neuroimmunol. 2014 Jun 27;274(0):71–77. doi: 10.1016/j.jneuroim.2014.06.021

Figure 3. STI1 expression in circulating blood monocytes and lymphocytes in glioma-bearing mice.

Figure 3

(A) Flow cytometry was performed to identify STI1–positive cells (red events) in blood after intracranial GL261 glioma inoculation. Representative dot plots demonstrating the expression of STI1 in monocytes (Mon; CD11b+/CD45high) and lymphocytes (Lym; CD11b−/CD45+) after gating the CD45+ (leukocyte) population. Quantification of the percentage of STI1–positive cells (B and D) and the mean fluorescence intensity (C and E) by cell type; n=4 animals per group; * p < 0.05, ** p < 0.01, *** p < 0.001. Data is representative of two separate experiments.